mesalamine has been researched along with Recrudescence in 269 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (2.60) | 18.7374 |
| 1990's | 72 (26.77) | 18.2507 |
| 2000's | 77 (28.62) | 29.6817 |
| 2010's | 100 (37.17) | 24.3611 |
| 2020's | 13 (4.83) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, B; Danese, S; Hart, A; Panaccione, R; Peyrin-Biroulet, L; Sandborn, WJ; Schreiber, S; Solitano, V | 1 |
| Arkenbosch, JHC; Beelen, EMJ; Bodelier, AGL; de Boer, NKH; de Vries, AC; Dijkstra, G; Erler, NS; Ho, JCL; Hoentjen, F; Mak, JWY; Ng, SC; Romberg-Camps, M; Stassen, LPS; van der Meulen, AE; van der Woude, CJ; van Ruler, O; West, R | 1 |
| Akturk, R; Serinsöz, S | 1 |
| Akol-Simsek, D; Colombel, JF; de Koning, DB; Fidder, HH; Goetgebuer, R; Hoentjen, F; Horjus-Talabur Horje, CS; Jansen, JM; Jharap, B; Lutgens, MWMD; Mahmmod, N; Mahmoud, R; Mares, W; Minderhoud, I; Oldenburg, B; Römkens, TEH; Savelkoul, EHJ; van Boeckel, PGA; van Schaik, FDM; van Tuyl, SAC; Witteman, BJM | 1 |
| Beilfuss, J; Florholmen, J; Goll, R; Gundersen, M; Johnsen, KM; Kileng, H; Moe, ØK; Sørbye, SW | 1 |
| Casanova, MJ; Gisbert, JP; Rojo, E | 1 |
| Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V | 1 |
| Bravo-Soto, GA; Candia, R; Hernandez, C; Monrroy, H; Nguyen, GC | 1 |
| Feagan, BG; MacDonald, JK; Murray, A; Nguyen, TM; Parker, CE | 1 |
| Al-Saedi, M; Alshahrani, AA; Aruljothy, A; Christensen, B; Fadida, M; Marshall, JK; Narula, N; Rubin, DT | 1 |
| Angelucci, E; Annese, V; Aratari, A; Biancone, L; Bossa, F; Cappello, M; Castiglione, F; Cottone, M; Di Mitri, R; Giunta, M; Kohn, A; Macaluso, FS; Mocciaro, F; Onali, S; Orlando, A; Papi, C; Renna, S; Rispo, A; Scimeca, D; Scribano, ML; Testa, A; Ventimiglia, M | 1 |
| Bajor, J; Faluhelyi, N; Hegyi, P; Hegyi, PJ; Németh, BC; Szakács, Z | 1 |
| Fukuzawa, M; Itoi, T; Kawai, T; Kono, S; Koyama, Y; Madarame, A; Matsumoto, T; Morise, T; Sugimoto, A; Suguro, M; Uchida, K; Yamaguchi, H; Yamauchi, Y; Yasuyuki, K | 1 |
| Bianchi, M; Chiesara, F; Dezi, A; Festa, V; Koch, M; Moretti, A; Spila Alegiani, S; Traversa, G | 1 |
| Hanai, H; Hibi, T; Kochi, S; Nagahori, M; Nakamura, S; Omuro, S; Watanabe, M; Yamamoto, T | 1 |
| Banai, J; Björck, S; Bunganic, I; Curtin, A; Derova, J; Diez Alonso, MM; Dilger, K; Dorofeyev, AE; Eisenbach, T; Ferreira, N; Greinwald, R; Kardalinos, V; Kondrackiene, J; Kruis, W; Lukas, M; Mäkelä, J; Mohrbacher, R; Pokrotnieks, J; Safadi, R; Spiller, R; Talley, NJ; Tuculanu, D; Tulassay, Z; Vich, T; Zakko, SF | 1 |
| Kuriyama, A; Matsumura, M; Urushidani, S | 1 |
| Nguyen, GC; Singh, S | 1 |
| Allocca, M; Armuzzi, A; Bonovas, S; Danese, S; Fiorino, G; Furfaro, F; Landi, R; Papa, A; Peyrin-Biroulet, L; Spinelli, A | 1 |
| Allez, M; Berset, IP; Burisch, J; Doherty, G; Gisbert, JP; Katsanos, KH; Kierkus, J; Lopetuso, L; Louis, E; Mao, R; Papamichael, K; Sebastian, S; Stallmach, A; Szymanska, E | 1 |
| Fukuda, T; Inoue, N; Iwao, Y; Kanai, T; Mizuno, S; Mutaguchi, M; Naganuma, M; Nakazato, Y; Nanki, K; Ogata, H; Sugimoto, S | 1 |
| Barreiro-de-Acosta, M; Beltrán, B; Bermejo, F; Cabré, E; Chaparro, M; Domènech, E; Garcia-Planella, E; García-Sánchez, V; Gisbert, JP; Gordillo, J; Llaó, J; Mañosa, M; Piqueras, M; Ricart, E | 1 |
| Astegiano, M; Caviglia, GP; Finocchiaro, F; Pellicano, R; Ribaldone, DG; Saracco, GM; Vernero, M | 1 |
| Ali, B; Hajibandeh, S; Khan, RMA | 1 |
| Jin, X; Lin, Z; Zhu, B | 1 |
| Ray, G | 1 |
| Carroll, M; Huynh, HQ; Kluthe, C; Spady, D; Tsui, J; Wine, E | 1 |
| Hegyi, P; Meczker, Á; Mikó, A | 1 |
| Akemoto, Y; Asari, T; Chinda, D; Fukuda, S; Fukutoku, Y; Hasui, K; Hiraga, H; Kikuchi, H; Mikami, T; Murai, Y; Sakuraba, H; Sawaya, M; Tanaka, M; Tatsuta, T | 1 |
| Anton, R; Ballester, MP; Bosca-Watts, MM; Fullana, M; Marti-Aguado, D; Minguez, M; Mora, F; Navarro-Cortes, P; Romero, E; Sanchez, A; Tosca, J | 1 |
| Kang, SB; Lee, J; Park, M; Park, Y | 1 |
| Akobeng, AK; Gjuladin-Hellon, T; Gordon, M; Iheozor-Ejiofor, Z | 1 |
| Annibale, B; Carabotti, M | 1 |
| Magowan, S; Quigley, EM; Shanahan, F; Stollman, N | 1 |
| Fan, C; Li, J; Liao, N; Liu, S; Ren, H; Ren, J; Wang, G; Wu, X; Zhao, Y | 1 |
| Bargiggia, S; Bortoli, A; Casella, G; De Pretis, G; Ferrari, A; Germanà, B; Giacosa, A; Miori, G; Parente, F; Prada, A | 1 |
| Hankins, M; Jones, M; Robinson, A; Wiseman, G | 1 |
| Chaparro, M; Díaz, R; Gisbert, JP; Rodríguez-Grau, Mdel C | 1 |
| Kanazawa, A; Kawaguchi, T; Okamoto, K; Sahara, R; Sako, M; Tadami, T; Takazoe, M; Yamana, T; Yoshimura, N | 1 |
| Farewell, D; Gillespie, D; Hawthorne, AB; Hood, K; Probert, C; Stenson, R | 1 |
| Bamba, T; Matsumoto, K; Shiraki, M; Umegae, S; Yamamoto, T | 1 |
| Fan, D; Wu, K; Wu, Q; Yang, Z; Ye, X | 1 |
| Dodd, J; Pavli, P; Platten, J; Richardson, A; Shadbolt, B; Subramaniam, K | 1 |
| Bernal, I; Boix, J; Cabré, E; Domènech, E; Lorenzo-Zúñiga, V; Mañosa, M; Marín, L; Moreno, V; Zabana, Y | 1 |
| Angelucci, E; Annese, V; Aratari, A; Biancone, L; Bossa, F; Cappello, M; Castiglione, F; Cottone, M; D'Incà, R; Fries, W; Gionchetti, P; Kohn, A; Lia Scribano, M; Martinato, M; Mocciaro, F; Onali, S; Orlando, A; Papi, C; Renna, S; Rispo, A; Rizzello, F; Scimeca, D; Tambasco, R; Testa, A; Vernia, P | 1 |
| Tursi, A | 2 |
| Aberra, FN; Brensinger, C; Cross, R; Gilroy, E; Hardi, R; Lewis, JD; Liakos, S; McCabe, R; Nessel, L; Osterman, MT; Shafran, I; Wolf, D | 1 |
| Hojsak, I; Kolaček, S; Pavić, AM | 1 |
| Akazawa, Y; Ichikawa, T; Isomoto, H; Makiyama, K; Matsumura, M; Nakao, K; Nishiyama, H; Ohba, K; Ohnita, K; Takeshima, F; Yamaguchi, N; Yamakawa, M; Yamao, T | 1 |
| Baldissarro, I; Bodini, G; de Cassan, C; Dulbecco, P; Fazio, V; Giambruno, E; Peyrin-Biroulet, L; Savarino, E; Savarino, V | 1 |
| Bell, S; Bennedsen, M; Burisch, J; Duricova, D; Haaber, A; Jess, T; Langholz, E; Martinsen, L; Munkholm, P; Pedersen, N; Thielsen, P; Végh, Z | 1 |
| Castro, AC; Chebli, JM; Chebli, LA; da Rocha Ribeiro, TC; de Lima Pace, FH; de Oliveira Zanini, KA; de Souza, GS; do Valle Pinheiro, B; Furtado, MC; Gaburri, PD; Machado de Oliveira, J; Pinto, AL; Ribeiro, LC; Vidigal, FM; Zanini, A | 1 |
| Carla-Moreau, A; Genin, C; Paul, S; Peyrin-Biroulet, L; Roblin, X | 1 |
| Burke, D; Kaye, TL; O'Connor, A; Tolan, DJ | 1 |
| Bain, JA | 1 |
| Matsumoto, K; Shimoyama, T; Yamamoto, T | 1 |
| Danese, S; Papa, A; Tursi, A | 1 |
| Avallone, EV; Cassieri, C; Cocco, A; Crispino, P; De Nitto, D; Marcheggiano, A; Occhigrossi, G; Paoluzi, P; Pica, R; Zippi, M | 1 |
| Dong, J; Gong, J; Li, J; Li, Y; Shen, X; Sun, J; Wang, H; Zhao, J; Zhu, W; Zuo, L | 1 |
| Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
| Barrett, AC; Bortey, E; Forbes, WP; Gordon, GL; Lichtenstein, GR; Murthy, U; Paterson, C; Pruitt, R; Sedghi, S; Zakko, S | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Contaldo, A; Di Leo, A; Iannone, A; Ierardi, E; Losurdo, G; Principi, M | 1 |
| Andersen, JT; Andersson, M; Bendtsen, F; Jess, T; Prosberg, MV; Vester-Andersen, MK; Vind, I | 1 |
| Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, HJ; Park, SJ; Park, Y | 1 |
| Brynskov, J; Ciocalteu, A; Hendel, J; Karstensen, JG; Klausen, P; Klausen, TW; Riis, LB; Săftoiu, A; Vilmann, P | 1 |
| Carpio, D; Fernandez-Salgado, E; Puga, M; Sampil, M; Zamora, MJ | 1 |
| Ali, B; Howden, CW; Khan, MA; Lee, WM | 1 |
| Feagan, BG; MacDonald, JK; Parker, CE; Wang, Y | 1 |
| Bahreini, Z; McGeer, A; Nguyen, GC; Razik, R; Rumman, A | 1 |
| Biedermann, L; D'cunja, J; Roose, L | 1 |
| Kim, CW; Kim, JC; Lee, JL; Lim, SB; Park, IJ; Yang, SK; Yoon, YS; Yu, CS | 1 |
| de Lima-Karagiannis, A; van der Woude, CJ; Zelinkova-Detkova, Z | 1 |
| Holmström, T; Karlbom, U; Rönnblom, A; Sjöberg, D; Tanghöj, H; Thörn, M | 1 |
| Andrade, P; Gomes, S; Macedo, G; Nunes, AC; Silva, M | 1 |
| Brandimarte, G; Di Mario, F; Elisei, W; Picchio, M; Scarpignato, C; Tursi, A | 1 |
| Barbara, G; Barbaro, MR; Bellacosa, L; Cremon, C; Stanghellini, V | 1 |
| Grand, RJ; Mandl, KD; Ong, MS | 1 |
| Picchio, M; Tursi, A | 1 |
| Bellolio, F; Cohen, Z; Fortinsky, KJ; Greenberg, G; Kevans, D; Macrae, H; McLeod, R; Milgrom, R; Qiang, J; Silverberg, MS; Steinhart, H; Stempak, J; Xu, W | 1 |
| Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB | 1 |
| Bresci, G; Capria, A; Parisi, G | 1 |
| Kruis, W; Leifeld, L | 1 |
| Cho, SW; Chung, JY; Hwang, JC; Lee, KJ; Park, BJ; Sin, SJ | 1 |
| Jang, BI; Kim, KO | 1 |
| Law, JK; Salh, B; Yoshida, EM | 1 |
| Cullen, G; Donnellan, F; Murray, FE | 1 |
| McKenzie, M; McLeod, RS; Parkes, R; Ross, S; Wolff, BG | 1 |
| Avnstrøm, S; Burisch, J; Elkjaer, M; Lynge, E; Munkholm, P | 1 |
| Ardia, A; Bellinvia, S; Campieri, M; Caprilli, R; Cottone, M; Kohn, A; Pallone, F; Prantera, C; Savarino, V; Sturniolo, GC; Vecchi, M | 1 |
| Baraboutis, IG; Georgiadis, D; Georgiou, O; Karamanolis, DG; Papastamopoulos, V; Rodias, M; Skoutelis, A; Viazis, N; Vlachogiannakos, J | 1 |
| Ji, ZL; Jiang, XH; Li, JS; Ren, JA; Tao, QS; Wang, XB | 1 |
| Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ | 1 |
| Casserly, LF; Dorman, AM; Peters, C; Shahrani Muhammad, HS; Watts, M | 1 |
| Bernal-Sprekelsen, JC; de las Marinas, MD; Landete, FJ; Morera, FJ; Salvador, A | 1 |
| Lakatos, L; Lakatos, PL | 1 |
| Kniazev, OV; Konopliannikov, AG; Lazebnik, LB; Parfenov, AI; Rogozina, VA; Ruchkina, IN | 1 |
| Annese, V; Brandimarte, G; D'Amico, T; Danese, S; Di Giulio, E; Di Rosa, S; Elisei, W; Forti, G; Gasbarrini, A; Giglio, A; Giorgetti, GM; Hassan, C; Imeneo, M; Larussa, T; Luzza, F; Modeo, ME; Morini, S; Papa, A; Pistoia, MA; Rodino', S; Sacca', N; Sebkova, L; Tursi, A | 1 |
| Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T | 1 |
| Bortey, E; Forbes, WP; Gordon, GL; Lichtenstein, GR; Merchant, K; Murthy, U; Pruitt, R; Sedghi, S; Shaw, A; Zakko, S | 1 |
| Matsumoto, K; Umegae, S; Yamamoto, T | 2 |
| Fujikawa, T; Iwabuchi, S; Kobayashi, K; Matsui, K; Shimizu, H; Takatsuka, K; Ueno, F; Yoshida, A; Yoshimatsu, E | 1 |
| Belaiche, J; Bello, C; Louis, E; Reenaers, C | 1 |
| Areni, A; Calabrese, C; Campieri, M; Fornarini, GS; Gionchetti, P; Liguori, G; Rizzello, F | 1 |
| Colombo, E; D'Incà, R; Fasoli, R; Gullotta, R; Lombardi, G; Meucci, G; Saibeni, S; Terpin, M; Valpiani, D | 1 |
| Barrett, K; Dolin, B; Jamal, MM; Kane, S; Katz, S; Palmen, M; Safdi, M; Solomon, D | 1 |
| Danese, S; Fiorino, G; Montorsi, M; Sacchi, M; Spinelli, A | 1 |
| Lubcke, R; Pan, A; Schlup, M; Schultz, M | 1 |
| Biancheri, P; Corazza, GR; Di Sabatino, A; Macdonald, TT; Rovedatti, L | 1 |
| Cabré, E; Domènech, E; Garcia-Planella, E; Gordillo, J; López San Román, A; Mañosa, M; Van Domselaar, M; Zabana, Y | 1 |
| Cho, SJ; Dalal, DH; Ferrell, LD; Heyman, MB; McCracken, M; Mileti, E; Perito, ER | 1 |
| Misago, N; Narisawa, Y | 1 |
| Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
| Bertoli, M; Filippini, A; Nicosia, F; Preti, S; Sabatini, T | 1 |
| Abe, J; Arai, H; Arai, O; Hanai, H; Iida, T; Ikeya, K; Maruyama, Y; Nakamura, K; Nakamura, T; Sugimoto, K; Takeuchi, K; Tanaka, T; Watanabe, F | 1 |
| Boermeester, MA; Daniels, L; Unlü, C; Vrouenraets, BC | 1 |
| Kelly, S | 1 |
| Cheon, JH; Hong, SP; Jung, YS; Kim, TI; Kim, WH; Park, SJ | 1 |
| Feagan, BG; Macdonald, JK | 1 |
| Ahuja, V; Kumar, A; Kumar, S; Moss, AC; Sankar, MJ | 1 |
| Fujimoto, K; Ikeda, Y; Iwakiri, R; Kishi, T; Nakano, R; Sakata, Y; Shimoda, R; Tsuruoka, N; Yamaguchi, K | 1 |
| Färkkilä, M; Järvinen, HJ; Jussila, A | 1 |
| Bertoni, M; Bresci, G; Capria, A; Parisi, G | 1 |
| Brandimarte, G; Daffinà, R; Tursi, A | 1 |
| Fleig, WE | 2 |
| Aikens, J; Hanauer, S; Huo, D; Kane, S | 1 |
| Nagy, F | 1 |
| Annese, V; Cammà, C; Caprilli, R; Castiglione, F; Corrao, G; Cottone, M; Latella, G; Papi, C; Sturniolo, G; Tonelli, F; Viscido, A | 1 |
| Rogozina, VA; Rumiantsev, VG | 1 |
| Kullak-Ublick, GA; Rammert, Ch | 1 |
| Moum, B | 1 |
| Gibson, JA; Green, JR; Kerr, GD; Swan, CH; Swarbrick, ET; Thornton, PC | 1 |
| Cermesoni, L; Cesana, BM; Piodi, LP; Ulivieri, FM | 1 |
| Andoh, A; Araki, Y; Bamba, T; Fujiyama, Y; Fukuda, M; Hanai, H; Kanauchi, O; Kojima, A; Mitsuyama, K; Sata, M; Takayuki, I; Takeuchi, K; Toyonaga, A | 1 |
| Fölsch, UR; Kühbacher, T; Schreiber, S | 1 |
| Regueiro, MD | 1 |
| Bischoff, SC; Fleig, W; Reissmann, A | 1 |
| Cuffari, C; Hanauer, S; Kane, SV; Lichtenstein, GR; Present, DH | 1 |
| Entani, A; Inatsuchi, S; Nakajima, T; Okada, K; Yoshio, Y | 1 |
| Beglinger, C; Fixa, B; Fric, P; Kamm, MA; Kascák, M; Kruis, W; Lukás, M; Pokrotnieks, J; Schulze, J; Stolte, M; Weismueller, J; Wolff, C | 1 |
| Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC | 1 |
| Bátovský, M; Fixa, B; Greinwald, R; Grigoryeva, G; Holomán, J; Hulek, P; Lukas, M; Marakhouski, Y; Rumyantsev, VG; Stolte, M; Vieth, M | 1 |
| Travis, SP | 1 |
| Caprilli, R; Chiaramonte, M; Corrao, G; Frieri, G; Galletti, B; Latella, G; Palumbo, G; Pimpo, M | 1 |
| Bellinvia, S; Prantera, C | 1 |
| Vetter, C | 1 |
| Consolazio, A; Crispino, P; Iacopini, F; Marcheggiano, A; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M | 1 |
| Ajayi, F; Hanauer, SB; Katz, S; Kornbluth, A; Regalli, G; Safdi, M; Sandborn, WJ; Smith-Hall, N; Woogen, S; Yeh, C | 1 |
| Adamek, HE; Rinas, U | 1 |
| Kane, SV | 1 |
| Adam, B; Holtmann, G; Liebregts, T | 1 |
| Keshav, S; Orchard, T; Probert, CS | 1 |
| Böhm, S; Kruis, W | 1 |
| Choi, CH; Kim, BC; Kim, HS; Kim, TI; Kim, WH; Lee, SK; Shin, SJ | 1 |
| Elta, G; Higgins, P; Korsnes, S; Menees, S | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, GM; Tursi, A | 1 |
| Araki, T; Inoue, M; Kusunoki, M; Miki, C; Ohkita, Y; Otake, K; Uchida, K | 1 |
| Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Tursi, A | 1 |
| Aslangul, E; Gadhoum, H; Le Jeunne, C; Perrot, S; Romnicianu, S; Szwebel, T | 1 |
| Hiwatashi, N; Iwabuchi, M; Kinouchi, Y; Kuriyama, S; Shimosegawa, T; Takagi, S; Takahashi, H; Takahashi, S; Tsuji, I; Yokoyama, H | 1 |
| Areni, A; Calabrese, C; Di Febo, G; Fabbri, A; Scialpi, C; Zahlane, D | 1 |
| Boltri, JM; Tindall, WN; Wilhelm, SM | 1 |
| Achkar, JP | 1 |
| Barrett, K; Joseph, R; Kamm, MA; Lees, K; Lichtenstein, GR; Sandborn, WJ; Schreiber, S | 1 |
| Gearry, RB; Gibson, PR; Irving, PM; James, SL | 1 |
| Edwards, CM; Probert, CS; Shah, JA | 1 |
| Actis, GC; Marzano, A; Pellicano, R; Rizzetto, M | 1 |
| Bartoli, F; Decorti, G; Malusa', N; Marino, S; Martelossi, S; Stocco, G; Ventura, A | 1 |
| Lichtenstein, GR; Rubin, DT; Sabesin, SM; Velayos, FS; Vitat, P | 1 |
| Dew, MJ; Evans, BK; Harries, AD; Hughes, P; Rhodes, J; Williams, G | 1 |
| Colombel, JF; Cortot, A; Desreumaux, P; Gambiez, L; Klein, O; Lescut, D; Quandalle, P | 1 |
| Andus, T; Gross, V; Schölmerich, J | 1 |
| Andrews, DF; Blair, JE; Cangemi, JR; Carryer, PW; Cohen, Z; Cullen, JB; McLeod, RS; O'Rourke, K; Steinhart, AH; Wolff, BG | 1 |
| Weber, P; Zimmer, KP | 1 |
| Arber, N; Becker, S; Broide, E; Bujanover, Y; Fireman, Z; Lavie, A; Moshkowitz, M; Odes, HS; Patz, J; Pomerantz, I | 1 |
| Ardizzone, S; Brignola, C; Cottone, M; D'Albasio, G; D'Arienzo, A; De Franchis, R; Pennestri, D; Pera, A; Scribano, ML | 1 |
| Schölmerich, J | 3 |
| Stark, ME; Tremaine, WJ | 1 |
| Koop, I | 1 |
| Andreoli, A; Levenstein, S; Prantera, C; Spinella, S | 1 |
| Howaldt, S; Raedler, A; Schreiber, S | 1 |
| Greenberger, NJ; Miner, PB | 1 |
| Rutgeerts, P | 2 |
| Andreoli, A; Assuero Lanfranchi, G; Caprilli, R; Capurso, L; Corrao, G; D'Albasio, G; Gioieni, A; Paladini, I; Pallone, F; Ponti, V | 1 |
| Hatzis, A; Mantzaris, GJ; Petraki, K; Spiliadi, C; Triantaphyllou, G | 1 |
| Ferry, GD | 1 |
| Barbara, L; Brunetti, G; Campieri, M; D'Albasio, G; Paoluzi, P; Pera, A | 1 |
| Allison, MC; Kapur, KC; Williams, GT | 1 |
| Bresci, G; Del Corso, L; Moruzzo, D; Norpoth, M; Pentimone, F; Romanelli, AM | 1 |
| Korelitz, BI | 1 |
| Ardizzone, S; Bianchi Porro, G; Desideri, S; Molteni, P; Petrillo, M | 1 |
| Caprilli, R; Corrao, G; Taddei, G; Tonelli, F; Torchio, P; Viscido, A | 1 |
| Belaïche, J; Cadiot, G; Colombel, JF; Costil, V; Danne, O; Dapoigny, M; Duclos, B; Dupas, JL; Galmiche, JP; Gendre, JP; Lamouliatte, H; Mary, JY; Modigliani, R; Soulé, JC; Veyrac, M | 1 |
| Belaiche, J; Cortot, A; Daurat, M; Dupas, JL; Faucheron, JL; Florent, C; Gendre, JP; Jacquet, N; Lerebours, E; Malafosse, M; Michot, F; Modigliani, R; Quandale, P; Rothman, N; Sahmound, T; Sarfaty, E; Soulé, JC; Valleur, P | 1 |
| Bodian, C; George, J; Pou, R; Present, DH; Rubin, PH | 1 |
| Mcleod, RS | 1 |
| Guslandi, M; Tittobello, A | 1 |
| David, V; Heloury, Y; Nomballais, MF; Plattner, V | 1 |
| Mary, JY; Sahmoud, T | 1 |
| Bailey, RJ; Dallaire, C; Fedorak, RN; Lariviere, L; Martin, F; Poleski, M; Rossman, R; Saibil, F; Sutherland, LR | 1 |
| Caprilli, R; Taddei, G; Viscido, A | 1 |
| Amorosi, A; Bardazzi, G; Biagini, M; Bonanomi, AG; Camarri, E; d'Albasio, G; Ferrero, S; Messori, A; Milla, M; Pacini, F; Quaranta, S; Trallori, G | 1 |
| Hanks, GE; Hanlon, AL; Peter, RS; Schultheiss, TE; Teshima, T | 1 |
| Buzio, C; De Rosa, A; Manenti, L | 1 |
| Miner, PB | 1 |
| Bell, CM; Habal, FM | 1 |
| Arber, N; Becker, S; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Shirin, C; Shirin, H; Villa, Y | 1 |
| Fernández, J; Feu, F; Navarro, S; Panés, J; Sala, M; Terés, J | 1 |
| Banti, S; Bertoni, M; Bresci, G; Capria, A; Gambardella, L; Parisi, G; Rindi, G | 1 |
| Crand, J; Foucault, M; Marteau, P; Rambaud, JC | 1 |
| Bosch, X | 1 |
| Rutgeerts, P; Vermeire, S | 1 |
| Bianchi Porro, G; Campieri, M; d'Albasio, G; Miglioli, M; Paoluzi, P; Pera, A; Prantera, C; Sturniolo, GC | 1 |
| Piccoli, DA; Sentongo, TA | 1 |
| Aigrain, Y; Besnard, M; Cézard, JP; Debrun, A; Delagausie, P; Faure, C; Ferkdadji, L; Jaby, O; Mougenot, JF; Navarro, J; Peuchmaur, M | 1 |
| Blum, HE; Volk-Zeiher, BA | 1 |
| Jauch, KW; Rentsch, M; Schölmerich, J | 1 |
| Andreoli, A; Annese, V; Caprilli, R; Comberlato, M; Corrao, G; Frieri, G; Palumbo, G; Pimpo, MT; Sturniolo, GC; Tonelli, F | 1 |
| Axon, AT; Chalmers, DM; Hawkey, PM; Rembacken, BJ; Snelling, AM | 1 |
| Brigidi, P; Campieri, M; Gionchetti, P; Johansson, R; Matteuzzi, D; Rizzello, F; Venturi, A; Zucconi, E | 1 |
| Gleim, GW; Kim, PS; Korelitz, BI; Zlatanic, J | 1 |
| Allan, RN; Langman, MJ | 1 |
| Guslandi, M | 1 |
| Bauer, P; Fleig, WE; Genser, D; Gross, V; Hoffmann, R; Lochs, H; Mayer, M; Mortensen, PB; Nesje, LB; Petritsch, W; Plauth, M; Raithel, M; Staun, M | 1 |
| Sutherland, LR | 2 |
| Achkar, JP; Hanauer, SB | 1 |
| Folwaczny, C | 1 |
| Good, LI; Goodman, MW; Haber, G; Hanauer, S; Lyss, C; Pizinger, RJ; Robinson, M; Strum, WB; Williams, CN | 1 |
| Cammà, C; Cottone, M | 1 |
| Guslandi, M; Mezzi, G; Sorghi, M; Testoni, PA | 1 |
| Broström, O; Danielsson, A; Florén, C; Hultcrantz, R; Järnerot, G; Kilander, A; Löfberg, R; Lööf, L; Nilsson, A; Ström, M | 1 |
| Bertoni, M; Bresci, G; Capria, A; Masolino, P; Parisi, G; Scatena, F | 1 |
| Ramadori, G; Schwörer, H | 1 |
| Rutgeerts, PJ | 1 |
| Acharya, V; Hwang, IP; Jordan, DR | 1 |
| Aoki, T; Eto, T; Imamura, T; Inatsu, H; Ishikawa, N; Nakajima, K; Ootsuka, M; Yamaga, J; Yuchi, H | 1 |
| Roberts, C; Robinson, A; Thompson, DG; Wilkin, D | 1 |
| Campbell, S; Ghosh, S | 1 |
| O'Morain, CA; Qasim, A; Seery, J | 1 |
| Marteau, P; Seksik, P | 1 |
| Gisbert, JP; Gomollón, F; Maté, J; Pajares, JM | 1 |
| Bergin, CF; Courtney, MG; Keeling, PW; Nunes, DP; O'Driscoll, M; Trimble, V; Weir, DG | 1 |
| Duncan, A; Nakshabendi, IM; Russell, RI | 1 |
| Goldstein, F | 1 |
| Gait, JE; Simerl, NA | 1 |
| Macrae, K; Record, CO | 1 |
| Hüppe, D; Krieg, M; Kuntz, HD; May, B; Schwegler, U; Thau, I; Tromm, A | 1 |
| Burakoff, R; Gorcey, S; Tripodi, J | 1 |
| Alstead, EM; Farthing, MJ; Wilson, AG | 1 |
| Barbara, L; Basso, O; Belluzzi, A; Brignola, C; Campieri, M; Gionchetti, P; Iannone, P; Miglioli, M; Pasquali, S | 1 |
| Banti, S; Bresci, G; Petrucci, A | 1 |
| Eliakim, R; Ligumsky, M; Rachmilewitz, D; Wengrower, D | 1 |
| d'Albasio, G; Ghetti, A; Milla, M; Morettini, A; Nucci, A; Pacini, F; Trallori, G | 1 |
| Biddle, WL; Miner, PB | 1 |
| Domínguez Palomo, S; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Pellicer Bautista, FJ; Romero Castro, R | 1 |
| Hartmann, F; Plauth, M | 1 |
| Breuer, N | 1 |
| Dölle, W; Hartmann, F | 1 |
| Greenberg, GR; Habal, FM | 1 |
| Dutt, S; Goodman, MJ; Herd, ME; Mani, V; Riley, SA; Turnberg, LA | 1 |
| Bukhave, K; Lauritsen, K; Laursen, LS; Rask-Madsen, J | 1 |
62 review(s) available for mesalamine and Recrudescence
| Article | Year |
|---|---|
Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Observational Studies as Topic; Proctitis; Recurrence | 2022 |
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2020 |
Probiotics for maintenance of remission in ulcerative colitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Middle Aged; Probiotics; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Young Adult | 2020 |
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Topics: Adalimumab; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asymptomatic Diseases; Azathioprine; Bias; Cohort Studies; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Purines; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Tumor Necrosis Factor-alpha | 2020 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Bias; Colitis, Ulcerative; Drug Administration Schedule; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2020 |
5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Databases, Bibliographic; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sulfasalazine; Treatment Outcome; Young Adult | 2018 |
Management of Crohn's Disease After Surgical Resection.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Colonoscopy; Crohn Disease; Digestive System Surgical Procedures; Disease Management; Gastrointestinal Agents; Humans; Immunologic Factors; Mesalamine; Recurrence; Risk Factors; Secondary Prevention; Smoking; Tumor Necrosis Factor-alpha | 2017 |
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Colitis, Ulcerative; Consensus; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Practice Guidelines as Topic; Recurrence; Retreatment; Secondary Prevention; Time Factors; Tumor Necrosis Factor-alpha; Withholding Treatment | 2018 |
Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Diverticulosis, Colonic; Humans; Mesalamine; Recurrence; Secondary Prevention; Treatment Outcome | 2018 |
5-ASA induces mild acute pancreatitis. Case report and review of the literature.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Mesalamine; Pancreatitis; Recurrence; Ultrasonography | 2018 |
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Quality of Life; Randomized Controlled Trials as Topic; Recurrence | 2019 |
Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Humans; Mesalamine; Recurrence; Secondary Prevention | 2019 |
A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn's disease.
Topics: Biological Products; Crohn Disease; Humans; Immunologic Factors; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2014 |
New physiopathological and therapeutic approaches to diverticular disease: an update.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colon; Dietary Fiber; Diverticulosis, Colonic; Humans; Mesalamine; Probiotics; Recurrence | 2014 |
Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Observational Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
A young woman with recurrent perianal sepsis.
Topics: Abscess; Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drainage; Female; Humans; Magnetic Resonance Imaging; Mesalamine; Perineum; Proctitis; Rectal Fistula; Recurrence; Sepsis; Treatment Outcome | 2015 |
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
Topics: Anti-Bacterial Agents; Dietary Fiber; Diverticulitis, Colonic; Diverticulum; Humans; Mesalamine; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin | 2015 |
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Multicenter Studies as Topic; Powders; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2016 |
Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Colitis, Ulcerative; Colon; Escherichia coli; Gastrointestinal Agents; Gastrointestinal Microbiome; Humans; Mesalamine; Odds Ratio; Probiotics; Recurrence; Remission Induction; Treatment Outcome | 2015 |
Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Humans; Mesalamine; Odds Ratio; Randomized Controlled Trials as Topic; Recurrence | 2016 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2016 |
[Ulcerative colitis].
Topics: Administration, Rectal; Adrenal Cortex Hormones; Algorithms; Colitis, Ulcerative; Colonoscopy; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Mesalamine; Middle Aged; Recurrence | 2016 |
Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Diverticulitis, Colonic; Humans; Mesalamine; Odds Ratio; Primary Prevention; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Treatment Outcome | 2016 |
[Postoperative recurrence of Crohn's disease, and its prevention].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Period; Recurrence; Risk Factors | 2010 |
Risk of postoperative recurrence and postoperative management of Crohn's disease.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Budesonide; Crohn Disease; Endoscopy; Gastroenterology; Humans; Inflammation; Mesalamine; Postoperative Period; Recurrence; Risk; Risk Factors; Treatment Outcome | 2011 |
Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.
Topics: Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Mesalamine; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2011 |
Recent advances in understanding ulcerative colitis.
Topics: Biopsy, Needle; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Megacolon, Toxic; Mesalamine; Precancerous Conditions; Prognosis; Recurrence; Risk Assessment; Severity of Illness Index; Survival Rate | 2012 |
Systematic review of medical therapy to prevent recurrent diverticulitis.
Topics: Anti-Bacterial Agents; Dietary Fiber; Diverticulitis; Humans; Mesalamine; Probiotics; Recurrence | 2012 |
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Medication Adherence; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Sulfasalazine | 2012 |
Curcumin for maintenance of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Drug Therapy, Combination; Humans; Maintenance Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 2012 |
[Can the postoperative relapse of Crohn disease be influenced?].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 2001 |
[Conservative therapy of inflammatory bowel diseases].
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prednisolone; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2002 |
[Management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Budesonide; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colonoscopy; Colorectal Neoplasms; Cyclosporins; Gastrointestinal Agents; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Interferons; Mercaptopurine; Mesalamine; Osteoporosis; Placebos; Practice Guidelines as Topic; Recurrence; Remission Induction; Risk Factors; Suppositories; Time Factors | 2003 |
[5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Recurrence | 2003 |
Ulcerative colitis: conservative management and long-term effects.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporins; Double-Blind Method; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferon-beta; Mercaptopurine; Mesalamine; Pilot Projects; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2004 |
Diagnosis and treatment of ulcerative proctitis.
Topics: Acute Disease; Diagnosis, Differential; Diarrhea; Hemorrhage; Humans; Mesalamine; Proctocolitis; Recurrence; Steroids; Treatment Outcome | 2004 |
[Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diverticulitis; Diverticulosis, Colonic; Diverticulum; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Peritonitis; Prognosis; Recurrence; Rifamycins; Rifaximin; Risk Factors; Tomography, X-Ray Computed | 2006 |
Systematic review: adherence issues in the treatment of ulcerative colitis.
Topics: Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Attitude to Health; Colitis, Ulcerative; Colorectal Neoplasms; Cost of Illness; Drug Administration Schedule; Health Care Costs; Humans; Mesalamine; Patient Compliance; Quality of Life; Recurrence | 2006 |
Review article: maintenance therapy in patients with ulcerative colitis.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colorectal Neoplasms; Drug Administration Schedule; Humans; Mesalamine; Patient Compliance; Peroxisome Proliferator-Activated Receptors; Recurrence; Time Factors; Treatment Outcome | 2006 |
[Probiotics in chronic inflammatory bowel disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Colitis, Ulcerative; Crohn Disease; Escherichia coli; Humans; Lactobacillus; Mesalamine; Placebos; Pouchitis; Practice Guidelines as Topic; Probiotics; Proctocolectomy, Restorative; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Streptococcus thermophilus; Time Factors | 2006 |
Management of distal ulcerative colitis: frequently asked questions analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Colitis, Ulcerative; Drug Administration Routes; Female; Glucocorticoids; Humans; Male; Mesalamine; Recurrence | 2008 |
Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Mesalamine; Recurrence; Risk Factors; Treatment Outcome; Treatment Refusal | 2008 |
[Crohn disease: prevention and drug therapy].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mesalamine; Pregnenediones; Recurrence | 1995 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
[Long-term therapy of Crohn disease].
Topics: Aminosalicylic Acids; Colon; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Long-Term Care; Mesalamine; Recurrence | 1993 |
[Treatment and recurrence prevention ulcerative colitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Humans; Mesalamine; Recurrence; Sulfasalazine | 1995 |
Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions?
Topics: Aminosalicylic Acids; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Postoperative Care; Recurrence | 1996 |
[Postoperative recurrence in Crohn's disease].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Recurrence | 1995 |
Factors influencing the relapse of patients with inflammatory bowel disease.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Humans; Infections; Inflammatory Bowel Diseases; Mesalamine; Recurrence; Risk Factors; Smoking | 1997 |
[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].
Topics: Anti-Inflammatory Agents; Budesonide; Colon; Crohn Disease; Follow-Up Studies; Humans; Ileum; Mesalamine; Metronidazole; Postoperative Complications; Recurrence | 1998 |
Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Male; Mesalamine; Pericarditis; Prednisone; Recurrence; Sulfasalazine | 1998 |
[Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas].
Topics: Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Postoperative Complications; Rectal Fistula; Recurrence | 1998 |
[Crohn disease--principle of longitudinal therapy planning with early surgical indications].
Topics: Crohn Disease; Humans; Longitudinal Studies; Mesalamine; Patient Care Planning; Patient Care Team; Postoperative Complications; Recurrence | 1998 |
Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Recurrence | 2000 |
Medical therapy to reduce postoperative Crohn's disease recurrence.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Mesalamine; Metronidazole; Recurrence; Risk Factors; Sulfasalazine | 2000 |
Mesalamine and relapse prevention in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Recurrence; Risk Assessment | 2000 |
[Guidelines of the DGVS. Acute process. German Society of Digestive and Metabolic Diseases].
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Mesalamine; Recurrence | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Recurrence | 2002 |
Maintenance treatment for Crohn's disease: has the time arrived?
Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 1992 |
[Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Recurrence | 1990 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Long-Term Care; Mesalamine; Prednisone; Recurrence; Sulfasalazine | 1989 |
79 trial(s) available for mesalamine and Recrudescence
| Article | Year |
|---|---|
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial.
Topics: Azathioprine; Crohn Disease; Double-Blind Method; Humans; Mesalamine; Recurrence | 2020 |
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Treatment Outcome | 2017 |
A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Colonic Diseases; Diverticulitis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mesalamine; Middle Aged; Probiotics; Recurrence; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; United States | 2013 |
Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Crohn Disease; Endoscopy; Female; Glycosides; Humans; Male; Mesalamine; Phytotherapy; Postoperative Period; Recurrence; Tripterygium | 2013 |
Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.
Topics: Adult; Aged; Aged, 80 and over; Confidence Intervals; Demography; Diverticulitis; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Pilot Projects; Placebos; Recurrence; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2013 |
Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Health Behavior; Humans; Male; Medication Adherence; Mesalamine; Micro-Electrical-Mechanical Systems; Middle Aged; Patient Compliance; Prognosis; Recurrence; Remission Induction | 2014 |
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colonoscopy; Crohn Disease; Female; Humans; Italy; Male; Mesalamine; Middle Aged; Postoperative Period; Prospective Studies; Recurrence; Severity of Illness Index; Time Factors; Young Adult | 2014 |
Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Feces; Humans; Leukocyte L1 Antigen Complex; Male; Mesalamine; Middle Aged; Recurrence; Treatment Outcome | 2014 |
Efficacy of long-term 4.0 g/day mesalazine (Pentasa) for maintenance therapy in ulcerative colitis.
Topics: Cohort Studies; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Japan; Kaplan-Meier Estimate; Maintenance Chemotherapy; Mesalamine; Recurrence; Retrospective Studies; Treatment Outcome | 2014 |
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal, Humanized; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reference Values; Risk Assessment; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome | 2014 |
Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Demography; Female; Humans; Ileocecal Valve; Intestinal Obstruction; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Recurrence; Smoking; Treatment Outcome; Young Adult | 2014 |
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Ulcerative; Colonoscopy; Female; Humans; Maintenance Chemotherapy; Male; Medication Adherence; Mesalamine; Middle Aged; Recurrence; Single-Blind Method; Treatment Outcome | 2015 |
Tripterygium wilfordii Hook F as Maintenance Treatment for Crohn's Disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Mesalamine; Patient Acuity; Phytotherapy; Plant Preparations; Recurrence; Remission Induction; Treatment Outcome; Tripterygium | 2015 |
Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
Topics: Adult; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Ileum; Immunosuppressive Agents; Male; Medication Adherence; Mesalamine; Multivariate Analysis; Recurrence; Risk Factors | 2009 |
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Female; Humans; Male; Mesalamine; Middle Aged; Patient Compliance; Recurrence; Treatment Outcome; Young Adult | 2009 |
[Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glycosides; Humans; Male; Mesalamine; Middle Aged; Phytotherapy; Postoperative Period; Recurrence; Treatment Outcome; Tripterygium; Young Adult | 2009 |
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lactobacillus; Male; Mesalamine; Middle Aged; Patient Selection; Probiotics; Recurrence; Remission Induction; Severity of Illness Index; Streptococcus thermophilus; Treatment Outcome | 2010 |
Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.
Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Hemorrhage; Humans; Male; Mesalamine; Middle Aged; Mucous Membrane; Rectum; Recurrence | 2010 |
High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Female; Humans; Male; Mesalamine; Prospective Studies; Recurrence; Severity of Illness Index | 2011 |
Clinical course of microscopic colitis in a single-center cohort study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Cholestyramine Resin; Cohort Studies; Colitis, Collagenous; Colitis, Lymphocytic; Diarrhea; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mesalamine; Multivariate Analysis; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2011 |
Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Administration Schedule; Female; Humans; Maintenance Chemotherapy; Male; Medication Adherence; Mesalamine; Middle Aged; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Time Factors | 2012 |
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Food, Formulated; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Longitudinal Studies; Maintenance Chemotherapy; Male; Mercaptopurine; Mesalamine; Recurrence; Young Adult | 2012 |
Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Child; Colitis, Ulcerative; Cytapheresis; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Granulocytes; Humans; Japan; Leukapheresis; Macrophages; Male; Mesalamine; Middle Aged; Monocytes; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2013 |
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mesalamine; Patient Compliance; Postoperative Complications; Recurrence; Treatment Outcome | 2003 |
[Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
Topics: Adult; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Recurrence; Sulfasalazine; Treatment Outcome | 2003 |
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Cohort Studies; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Patient Participation; Phenylhydrazines; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2004 |
Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis, Ulcerative; Cost-Benefit Analysis; Enema; Female; Health Care Costs; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2004 |
Germinated barley foodstuff prolongs remission in patients with ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Dietary Fiber; Female; Germination; Hordeum; Humans; Male; Mesalamine; Phytotherapy; Plant Preparations; Recurrence; Remission, Spontaneous; Steroids | 2004 |
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Escherichia coli; Female; Humans; Male; Mesalamine; Middle Aged; Probiotics; Recurrence; Remission Induction | 2004 |
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Tablets; Treatment Outcome | 2005 |
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Drug; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Time Factors; Treatment Outcome | 2005 |
The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Ileitis; Mesalamine; Recurrence; Treatment Outcome | 2005 |
Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Mesalamine; Middle Aged; Patient Compliance; Recurrence; Remission Induction; Single-Blind Method | 2005 |
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Placebos; Recurrence; Remission Induction; Safety; Treatment Outcome | 2005 |
Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon.
Topics: Aged; Aged, 80 and over; Diverticulum, Colon; Female; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2007 |
Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Lacticaseibacillus casei; Male; Mesalamine; Middle Aged; Phenylhydrazines; Pilot Projects; Probiotics; Recurrence; Treatment Outcome | 2007 |
Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Administration Schedule; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2007 |
Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Biopsy; Chi-Square Distribution; Cholestyramine Resin; Colitis, Microscopic; Colonoscopy; Drug Therapy, Combination; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Treatment Outcome | 2007 |
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Colitis, Ulcerative; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Patient Compliance; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome | 2008 |
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
Topics: Acrylic Resins; Administration, Oral; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Polymethacrylic Acids; Random Allocation; Recurrence; Sulfasalazine; Tablets, Enteric-Coated | 1982 |
Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
Topics: Adult; Aminosalicylic Acids; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colonoscopy; Crohn Disease; Female; Humans; Ileum; Male; Mesalamine; Prospective Studies; Recurrence; Time Factors | 1995 |
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Confidence Intervals; Crohn Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mesalamine; Pancreatitis; Patient Compliance; Recurrence; Risk Factors | 1995 |
A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Double-Blind Method; Female; Humans; Male; Mesalamine; Recurrence; Treatment Outcome | 1995 |
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Regression Analysis; Treatment Outcome | 1995 |
5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Drug Administration Schedule; Enema; Female; Follow-Up Studies; Humans; Male; Mesalamine; Prospective Studies; Recurrence; Sulfasalazine; Time Factors | 1994 |
Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.
Topics: Administration, Oral; Aminosalicylic Acid; Aminosalicylic Acids; Crohn Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Lymphocyte Count; Male; Mesalamine; Pilot Projects; Receptors, Interleukin-2; Recurrence; T-Lymphocytes; Treatment Outcome | 1994 |
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Topics: Administration, Oral; Adolescent; Adult; Aminosalicylic Acids; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence | 1994 |
Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Administration Schedule; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Proctitis; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Ulcer | 1994 |
IBD: which 5-ASA drug works where?
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Recurrence | 1993 |
Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.
Topics: Administration, Rectal; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Enema; Female; Humans; Male; Mesalamine; Patient Acceptance of Health Care; Prospective Studies; Recurrence; Single-Blind Method; Time Factors | 1993 |
[5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Survival Analysis; Time Factors | 1995 |
Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
Topics: Acrylic Resins; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Female; Humans; Life Tables; Male; Mesalamine; Polymethacrylic Acids; Prospective Studies; Recurrence; Sulfasalazine; Tablets, Enteric-Coated; Time Factors | 1995 |
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Crohn Disease; Female; Follow-Up Studies; Humans; Life Tables; Male; Mesalamine; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Factors | 1996 |
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Belgium; Chi-Square Distribution; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Logistic Models; Male; Mesalamine; Prednisolone; Proportional Hazards Models; Recurrence; Remission Induction | 1996 |
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Colonic Diseases; Colonoscopy; Constriction, Pathologic; Crohn Disease; Double-Blind Method; Drug Tolerance; Female; Humans; Ileal Diseases; Male; Mesalamine; Middle Aged; Placebos; Recurrence; Ulcer | 1996 |
Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis.
Topics: Administration, Cutaneous; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mesalamine; Nicotine; Pilot Projects; Recurrence; Steroids; Time Factors; Treatment Outcome | 1996 |
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Double-Blind Method; Female; Humans; Male; Mesalamine; Recurrence; Treatment Outcome | 1997 |
Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Combined Modality Therapy; Double-Blind Method; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence | 1997 |
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chronic Disease; Crohn Disease; Double-Blind Method; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Status; Humans; Immunosuppressive Agents; Israel; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Placebos; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Recurrence; Suppositories | 1998 |
Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Proctitis; Recurrence; Suppositories | 1998 |
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Escherichia coli; Female; Gentamicins; Humans; Intestines; Male; Mesalamine; Middle Aged; Probiotics; Recurrence; Remission Induction | 1999 |
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
Topics: Adult; Aged; Bifidobacterium; Colitis, Ulcerative; Feces; Female; Humans; Hydrogen-Ion Concentration; Lactobacillus; Male; Mesalamine; Middle Aged; Probiotics; Recurrence; Streptococcus | 1999 |
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Double-Blind Method; Europe; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Placebos; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2000 |
[Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Combined Modality Therapy; Double-Blind Method; Escherichia coli; Humans; Mesalamine; Middle Aged; Probiotics; Recurrence; Treatment Outcome | 2000 |
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Remission Induction; Suppositories; Time Factors | 2000 |
Saccharomyces boulardii in maintenance treatment of Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Probiotics; Recurrence; Saccharomyces; Treatment Outcome | 2000 |
Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis.
Topics: Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Sweden | 2000 |
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Prednisolone; Quality of Life; Recurrence; Self Care; Surveys and Questionnaires; Time Factors | 2001 |
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Life Tables; Male; Mesalamine; Middle Aged; Patient Compliance; Recurrence; Remission Induction | 1992 |
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.
Topics: Administration, Oral; Aminosalicylic Acids; C-Reactive Protein; Crohn Disease; Humans; Mesalamine; Orosomucoid; Placebos; Recurrence | 1992 |
Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 1990 |
Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Crohn Disease; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Tablets, Enteric-Coated | 1990 |
[5-aminosalicylic acid in the long-term treatment of ulcerative colitis].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Long-Term Care; Male; Mesalamine; Random Allocation; Recurrence | 1989 |
[Prevention of recurrence of chronic inflammatory bowel diseases].
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Long-Term Care; Mesalamine; Prednisone; Recurrence; Sulfasalazine | 1989 |
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Sulfasalazine | 1989 |
Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Sulfasalazine | 1988 |
Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Middle Aged; Random Allocation; Recurrence; Sulfasalazine | 1988 |
Colonic prostaglandin E2 levels and olsalazine metabolism in relapsing ulcerative colitis: implications for controlled trials in the long term.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Colon; Dinoprostone; Female; Follow-Up Studies; Humans; Male; Mesalamine; Recurrence; Time Factors | 1988 |
129 other study(ies) available for mesalamine and Recrudescence
| Article | Year |
|---|---|
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
Topics: Bayes Theorem; Constriction, Pathologic; Crohn Disease; Humans; Ileum; Mesalamine; Prognosis; Recurrence; Retrospective Studies | 2022 |
The role of mesalazine co-treatment in the prevention of recurrence in subjects with subclinical inflammatory bowel disease and perianal fistula who are scheduled for surgical intervention.
Topics: Colonoscopy; Humans; Inflammatory Bowel Diseases; Mesalamine; Rectal Fistula; Recurrence; Retrospective Studies; Treatment Outcome | 2022 |
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease.
Topics: Adult; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Humans; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Prospective Studies; Recurrence; Remission Induction; Tumor Necrosis Factor Inhibitors | 2023 |
Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.
Topics: Colitis, Ulcerative; Follow-Up Studies; Humans; Mesalamine; Recurrence; Remission Induction; Tumor Necrosis Factor Inhibitors | 2022 |
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
Topics: Adolescent; Adult; Colitis, Ulcerative; Colonoscopy; Female; Humans; Intestinal Mucosa; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Young Adult | 2020 |
Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis.
Topics: Acute Disease; Adult; Azathioprine; Colitis, Ulcerative; Humans; Male; Mesalamine; Pancreatitis; Recurrence | 2020 |
Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Tapering; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Young Adult | 2021 |
Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis.
Topics: Adult; Aged; Aged, 80 and over; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome | 2017 |
Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Compounding; Female; Humans; Japan; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Recurrence; Severity of Illness Index; Sulfasalazine; Young Adult | 2017 |
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colonoscopy; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Postoperative Period; Proportional Hazards Models; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
Topics: Adult; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Registries; Risk Factors; Young Adult | 2017 |
Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Colitis, Ulcerative; Colonoscopy; Feces; Female; Humans; Intestinal Mucosa; Leukocyte L1 Antigen Complex; Logistic Models; Male; Mesalamine; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Spain | 2018 |
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Inflammatory Bowel Diseases; Italy; Male; Medication Adherence; Mesalamine; Middle Aged; Multivariate Analysis; Prospective Studies; Recurrence; Regression Analysis; Severity of Illness Index; Sex Distribution; Young Adult | 2018 |
Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting: A case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diabetes Mellitus; Diagnostic Techniques, Ophthalmological; Fasting; HLA-B27 Antigen; Humans; Male; Mesalamine; Middle Aged; Ophthalmic Solutions; Recurrence; Spondylitis, Ankylosing; Treatment Outcome; Uveitis, Anterior | 2018 |
Long-term maintenance treatment of ulcerative colitis in eastern India: a 15-year follow-up.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; India; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Prospective Studies; Recurrence; Young Adult | 2018 |
The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
Topics: Adalimumab; Adolescent; Ambulatory Care Facilities; Analysis of Variance; Canada; Child; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Hospitals, Pediatric; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Medication Adherence; Mesalamine; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome | 2018 |
A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine.
Topics: Antineoplastic Agents, Immunological; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Male; Mesalamine; Middle Aged; Nivolumab; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 2019 |
Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system.
Topics: Adult; Colitis, Ulcerative; Electronic Prescribing; Female; Humans; Male; Medication Adherence; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Risk Factors; Time Factors | 2019 |
Recurrent Eosinophilic Pneumonia Associated with Mesalazine Suppository in a Patient with Ulcerative Colitis.
Topics: Adult; Anti-Inflammatory Agents; Budesonide; Colitis, Ulcerative; Colonoscopy; Female; Humans; Mesalamine; Methylprednisolone; Pneumonia; Probiotics; Pulmonary Eosinophilia; Recurrence; Thorax; Tomography, X-Ray Computed | 2019 |
Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Drug Substitution; Female; Humans; Inflammatory Bowel Diseases; Male; Medication Adherence; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; United Kingdom; Young Adult | 2013 |
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; Drug Substitution; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, B-Cell, Marginal Zone; Mesalamine; Methylprednisolone; Rectovaginal Fistula; Recurrence; Remission Induction; Stomach Neoplasms | 2014 |
Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn's disease: a retrospective analysis of 258 patients.
Topics: Adult; Crohn Disease; Female; Humans; Maintenance Chemotherapy; Male; Mesalamine; Panax; Plant Extracts; Postoperative Care; Recurrence; Remission Induction; Reoperation; Retrospective Studies; Time Factors; Zanthoxylum; Zingiberaceae | 2014 |
Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Colitis, Ulcerative; Feces; Female; Humans; Lactoferrin; Leukocyte L1 Antigen Complex; Male; Mesalamine; Middle Aged; Recurrence; Remission Induction; Young Adult | 2014 |
Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colectomy; Colitis, Ulcerative; Disease-Free Survival; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Middle Aged; Observational Studies as Topic; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
Topics: Adolescent; Adult; Azathioprine; Case-Control Studies; Crohn Disease; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Humans; Male; Mesalamine; Moraceae; Recurrence; Retrospective Studies; Young Adult | 2014 |
Mesalamine treatment mimicking relapse in a child with ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Mesalamine; Recurrence | 2014 |
eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Computer-Assisted Instruction; Drug Administration Schedule; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Internet; Male; Medication Adherence; Mesalamine; Middle Aged; Patient Education as Topic; Precision Medicine; Prognosis; Prospective Studies; Quality of Life; Recurrence; Self Care; Severity of Illness Index; Telemedicine; Young Adult | 2014 |
Mesalamine-induced fever: an important reminder to prescribers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Fever; Humans; Male; Mesalamine; Middle Aged; Recurrence; Risk Factors; Ulcer | 2015 |
Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Colitis, Ulcerative; Endoscopy; Feces; Female; Humans; Leukocyte L1 Antigen Complex; Male; Mesalamine; Middle Aged; Proctitis; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Suppositories; Wound Healing; Young Adult | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Patient Compliance; Prognosis; Recurrence; Risk Factors; Self Care; Time Factors | 2016 |
Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Disease Progression; Female; Humans; Intestinal Mucosa; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Republic of Korea; Retrospective Studies; Severity of Illness Index; Wound Healing; Young Adult | 2016 |
Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos).
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Colitis, Ulcerative; Colonoscopy; Female; Fluorescein; Fluorescent Dyes; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Intravital Microscopy; Longitudinal Studies; Male; Mesalamine; Microscopy, Confocal; Middle Aged; Recurrence; Treatment Outcome; Young Adult | 2016 |
Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chorioretinitis; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Mesalamine; Recurrence; Toxoplasmosis, Ocular | 2016 |
Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Topics: Adalimumab; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis, Ulcerative; Crohn Disease; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Agents; Glucocorticoids; Hospitalization; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Young Adult | 2016 |
Surgical Treatment of Crohn Colitis Involving More Than 2 Colonic Segments: Long-Term Outcomes From a Single Institution.
Topics: Adult; Age of Onset; Colectomy; Colitis; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Nutritional Status; Postoperative Complications; Recurrence; Retrospective Studies; Risk Factors; Survival; Young Adult | 2016 |
The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Infant, Newborn; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prospective Studies; Recurrence; Tumor Necrosis Factor-alpha | 2016 |
Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.
Topics: Adult; Aged; Aged, 80 and over; Colectomy; Colitis, Ulcerative; Disease Progression; Female; Humans; Immunologic Factors; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Severity of Illness Index; Steroids; Sweden; Young Adult | 2016 |
Collagenous colitis and Crohn's disease: Guilty or innocent bystander?
Topics: Aged; Budesonide; Colitis, Collagenous; Colon; Colonoscopy; Crohn Disease; Humans; Male; Mesalamine; Recurrence | 2016 |
Prognostic Role of the Endoscopic Classification "DICA".
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Colon; Colonoscopy; Diverticulosis, Colonic; Diverticulum; Feces; Female; Humans; Leukocyte L1 Antigen Complex; Male; Mesalamine; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies | 2016 |
Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Diverticulosis, Colonic; Humans; Mesalamine; Recurrence; Treatment Outcome | 2016 |
Trends in Pharmacologic Interventions for Preventing Recurrence of Crohn's Disease After Ileocolonic Surgery.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biological Factors; Colectomy; Colon; Crohn Disease; Databases, Factual; Disease Progression; Female; Humans; Ileum; Male; Mesalamine; Middle Aged; Postoperative Period; Recurrence; Retrospective Studies; Secondary Prevention; United States | 2016 |
Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colon; Crohn Disease; Endoscopy, Digestive System; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Postoperative Care; Proportional Hazards Models; Recurrence; Retrospective Studies; Secondary Prevention | 2017 |
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis, Ulcerative; Colon; Constriction, Pathologic; Crohn Disease; Deprescriptions; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mesalamine; Middle Aged; Probability; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome; Young Adult | 2008 |
[Modern therapy of diverticular disease].
Topics: Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colonoscopy; Combined Modality Therapy; Cross-Sectional Studies; Diverticulitis, Colonic; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Mesalamine; Middle Aged; Patient Care Team; Recurrence; Referral and Consultation | 2008 |
[Relapse rates of ulcerative colitis in remission and factors related to relapse].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemoglobins; Humans; Male; Mesalamine; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Time Factors | 2008 |
[Relapse of ulcerative colitis in remission].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Chronic Disease; Colitis, Ulcerative; Hemoglobins; Humans; Mesalamine; Recurrence; Risk Factors | 2008 |
All that bleeds is not infliximab-refractory ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Asian People; Colitis, Ulcerative; Drug Resistance; Gastrointestinal Hemorrhage; Glucocorticoids; Humans; Infliximab; Laser Therapy; Male; Mesalamine; Rectum; Recurrence; Sigmoidoscopy | 2009 |
New-onset ulcerative colitis in a patient treated with the anti-CD11a monoclonal antibody efalizumab.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; CD11 Antigens; Colitis, Ulcerative; Colonoscopy; Drug Therapy, Combination; Glucocorticoids; Humans; Hydrocortisone; Injections, Intravenous; Male; Mesalamine; Radiography, Abdominal; Recurrence | 2009 |
Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Colitis, Ulcerative; Computer-Assisted Instruction; Denmark; Depression; Female; Humans; Internet; Male; Mesalamine; Middle Aged; Patient Compliance; Patient Education as Topic; Quality of Life; Randomized Controlled Trials as Topic; Recurrence | 2010 |
Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiretroviral Therapy, Highly Active; Azathioprine; CD4 Lymphocyte Count; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; HIV Infections; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors | 2010 |
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intestinal Diseases; Korea; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Ulcer; Young Adult | 2010 |
Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Crohn Disease; Diagnosis, Differential; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Kidney Tubules; Male; Mesalamine; Nephritis, Interstitial; Recurrence | 2010 |
Recurrent pericarditis in a patient with ulcerative proctitis due to mesalazine suppositories.
Topics: Humans; Male; Mesalamine; Middle Aged; Pericarditis; Proctitis; Radiography, Thoracic; Recurrence; Suppositories; Tomography, X-Ray Computed | 2010 |
[Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Colitis, Ulcerative; Female; Glucocorticoids; Humans; Male; Mesalamine; Mesenchymal Stem Cell Transplantation; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous | 2010 |
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome | 2010 |
Possible role of early transabdominal ultrasound in patients undergoing cytapheresis for active ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Colitis, Ulcerative; Colon; Cytapheresis; Female; Humans; Immunologic Factors; Male; Mesalamine; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Time Factors; Treatment Outcome; Ultrasonography; Young Adult | 2011 |
Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Mesalamine; Middle Aged; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Young Adult | 2011 |
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Endoscopy; Female; Humans; Male; Mesalamine; Middle Aged; Prognosis; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Young Adult | 2012 |
Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Male; Mesalamine; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Solitary rectal ulcer syndrome in children and adolescents.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Laxatives; Male; Mesalamine; Proctoscopy; Rectal Diseases; Recurrence; Retrospective Studies; Suppositories; Syndrome; Treatment Outcome; Ulcer | 2012 |
Erythema induratum (nodular vasculitis) associated with Crohn's disease: a rare type of metastatic Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Erythema Induratum; Female; Glucocorticoids; Humans; Leg; Mesalamine; Middle Aged; Prednisone; Recurrence; Remission Induction; Treatment Outcome | 2012 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Granulocytes; Humans; Kaplan-Meier Estimate; Leukapheresis; Longitudinal Studies; Male; Mesalamine; Monocytes; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Substance-Related Disorders; Sulfasalazine; Treatment Outcome | 2012 |
Recurrence of myocarditis after mesalazine treatment for ulcerative colitis: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Male; Mesalamine; Myocarditis; Recurrence; Young Adult | 2013 |
Ulcerative colitis.
Topics: Anecdotes as Topic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis, Ulcerative; Diagnostic Errors; Disease Progression; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Patient Acceptance of Health Care; Recurrence; Shame; Students; Treatment Outcome; Young Adult | 2012 |
Clinical course of intestinal Behcet's disease during the first five years.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Disease Progression; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Mesalamine; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Sulfasalazine | 2013 |
Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Prognosis; Recurrence; Remission Induction; Severity of Illness Index | 2002 |
Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Recurrence; Rifamycins; Rifaximin; Severity of Illness Index; Time; Treatment Outcome | 2002 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors | 2003 |
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Recurrence; Treatment Refusal | 2003 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Humans; Mesalamine; Patient Compliance; Recurrence; Remission Induction; Severity of Illness Index | 2004 |
[Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Colitis, Ulcerative; Drug Hypersensitivity; Enema; Humans; Male; Mesalamine; Recurrence; Treatment Outcome | 2004 |
Preventive therapy for complicated diverticular disease of the colon: looking for a correct therapeutic approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Diverticulitis, Colonic; Humans; Inflammation; Intestinal Perforation; Mesalamine; Probiotics; Recurrence | 2004 |
Crohn's disease over 20 years after diagnosis in a referral population.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires | 2004 |
Dose escalation of 5ASA: does it work?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Mesalamine; Recurrence; Treatment Outcome | 2005 |
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Immunosuppressive Agents; Mesalamine; Recurrence; Risk Factors; Time Factors; Ursodeoxycholic Acid | 2005 |
[Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Escherichia coli; Female; Humans; Male; Mesalamine; Middle Aged; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Remission Induction | 2006 |
Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Fungal; Behcet Syndrome; Case-Control Studies; Female; Fluorescent Antibody Technique, Indirect; Humans; Intestinal Diseases; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; Saccharomyces cerevisiae; Treatment Outcome | 2006 |
Does colonoscopy cause increased ulcerative colitis symptoms?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Cross-Over Studies; Female; Glucocorticoids; Humans; Male; Mesalamine; Middle Aged; Prednisone; Recurrence | 2007 |
Successful treatment with topical 5-aminosalicylic acid ointment and spray of refractory oral and pharyngeal ulcerations in a child with Crohn disease.
Topics: Administration, Topical; Aerosols; Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Female; Humans; Mesalamine; Ointments; Oral Ulcer; Pharyngeal Diseases; Recurrence | 2007 |
Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Male; Mesalamine; Middle Aged; Pericarditis; Recurrence; Sulfasalazine | 2007 |
Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Disease Progression; Female; Health Care Costs; Humans; Male; Managed Care Programs; Mesalamine; Patient Compliance; Pharmacists; Professional Role; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Treatment Outcome | 2007 |
Ulcerative colitis: responding to the challenges.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Immunologic Factors; Infliximab; Male; Mesalamine; Recurrence; Sulfasalazine; Treatment Outcome | 2007 |
Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Medical Audit; Mesalamine; Methyltransferases; Recurrence; Retrospective Studies; Treatment Outcome | 2008 |
How important is mesalamine in the maintenance of steroid-refractory colitis?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colitis, Ulcerative; Drug Resistance; Humans; Male; Mesalamine; Recurrence; Remission Induction; Steroids | 2008 |
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child, Preschool; Colitis, Ulcerative; Drug Interactions; Drug Therapy, Combination; Humans; Mesalamine; Patient Compliance; Recurrence | 2008 |
[Crohn's disease and tobacco consumption].
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cannabis; Crohn Disease; Designer Drugs; Humans; Male; Mesalamine; Prednisolone; Recurrence; Smoking; Substance-Related Disorders; Time Factors | 1995 |
[Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Topics: Aminosalicylic Acids; Chronic Disease; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methylprednisolone; Recurrence; Sulfasalazine | 1995 |
[Is preventive drug therapy of recurrent Crohn disease indicated after ileocecal resection?].
Topics: Aminosalicylic Acids; Cecum; Combined Modality Therapy; Crohn Disease; Humans; Ileum; Mesalamine; Recurrence; Sulfasalazine | 1994 |
Is maintenance therapy effective in Crohn's disease?
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Meta-Analysis as Topic; Prednisone; Recurrence; Sulfasalazine | 1994 |
Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Crohn Disease; Humans; Ileitis; Mesalamine; Recurrence; Sulfasalazine | 1994 |
Mesalazine induced exacerbation of ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon, Sigmoid; Humans; Male; Mesalamine; Recurrence | 1995 |
Drug choice in preventing postoperative Crohn's disease.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Postoperative Complications; Recurrence | 1996 |
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Colitis, Ulcerative; Female; Humans; Life Tables; Male; Mercaptopurine; Mesalamine; Prednisone; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 1996 |
[Bilateral pneumothorax and hemorrhagic rectocolitis].
Topics: Adolescent; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Mesalamine; Pneumothorax; Recurrence | 1996 |
Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Crohn Disease; Humans; Mesalamine; Recurrence | 1997 |
Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity.
Topics: Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Hemorrhage; Humans; Male; Mesalamine; Middle Aged; Multivariate Analysis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Rectal Diseases; Recurrence; Time Factors | 1997 |
Mesalazine-associated interstitial nephritis: twice in the same patient.
Topics: Adult; Colitis, Ulcerative; Humans; Male; Mesalamine; Nephritis, Interstitial; Recurrence | 1997 |
Safety of topical 5-aminosalicylic acid in pregnancy.
Topics: Abnormalities, Drug-Induced; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Enema; Female; Fertilization; Follow-Up Studies; Humans; Infant, Newborn; Mesalamine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Recurrence; Safety; Suppositories; Treatment Outcome | 1997 |
Acute pancreatitis after long-term 5-aminosalicylic acid therapy.
Topics: Acute Disease; Adult; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Lipase; Male; Mesalamine; Pancreatitis; Recurrence | 1997 |
Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enema; Evaluation Studies as Topic; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence | 1997 |
Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Crohn Disease; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Male; Mesalamine; Middle Aged; Prednisone; Recurrence; Vitamin D | 1998 |
Postoperative outcome of Crohn's disease in 30 children.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Mesalamine; Postoperative Care; Recurrence; Risk Factors; Treatment Outcome | 1998 |
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Cross-Sectional Studies; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence | 1999 |
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Confidence Intervals; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Probability; Proportional Hazards Models; Recurrence; Remission Induction; Sex Factors; Time Factors | 1999 |
Escherichia coli for ulcerative colitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Escherichia coli; Humans; Mesalamine; Recurrence; Remission Induction | 1999 |
Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Mesalamine; Nicotine; Prednisone; Recurrence; Remission Induction | 1999 |
Does the initial location of Crohn's disease have an influence on the time-to-relapse in patients under maintenance treatment with oral mesalamine?
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Crohn Disease; Female; Humans; Ileitis; Male; Mesalamine; Prognosis; Recurrence; Time Factors | 2000 |
[Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colonoscopy; Crohn Disease; Female; Humans; Intestinal Mucosa; Mesalamine; Pancreatitis; Recurrence; Retreatment | 2000 |
Lacrimal gland inflammation as the presenting sign of Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dacryocystitis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Mesalamine; Orbital Pseudotumor; Prednisone; Recurrence; Tomography, X-Ray Computed | 2001 |
Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Echocardiography; Electrocardiography; Humans; Male; Mesalamine; Pericarditis; Prednisolone; Recurrence; Severity of Illness Index | 2001 |
Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies | 2001 |
Aminosalicylate as prophylaxis for Crohn's disease.
Topics: Anastomosis, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesalamine; Recurrence | 2001 |
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Escherichia coli; Freeze Drying; Gastrointestinal Agents; Humans; Mesalamine; Placebos; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Saccharomyces; Time Factors | 2001 |
Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Topics: Acrylic Resins; Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; Sulfasalazine; Tablets, Enteric-Coated | 1992 |
Comparisons of olsalazine and mesalazine in prevention of relapse in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Recurrence; Research Design | 1992 |
Mesalazine versus olsalazine for prophylaxis of ulcerative colitis relapse.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Recurrence | 1992 |
[Serum cholinesterases as activity parameters in chronic inflammatory bowel diseases].
Topics: Acute-Phase Proteins; Adolescent; Adult; Aged; Aminosalicylic Acids; Child; Cholinesterases; Colitis, Ulcerative; Crohn Disease; Female; Hematocrit; Humans; Male; Mesalamine; Middle Aged; Platelet Count; Recurrence; Retrospective Studies; Serum Albumin; Sulfasalazine | 1992 |
A case of diversion colitis treated with 5-aminosalicylic acid enemas.
Topics: Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis; Colostomy; Diverticulum, Colon; Enema; Female; Humans; Mesalamine; Recurrence | 1992 |
Lichen planus and mesalazine.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Lichen Planus; Male; Mesalamine; Middle Aged; Recurrence; Sulfasalazine | 1991 |
5-aminosalicylic acid in the prevention of relapses of Crohn's disease in remission: a long-term study.
Topics: Adult; Aminosalicylic Acids; Crohn Disease; Female; Humans; Male; Mesalamine; Recurrence | 1991 |
Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Drug Evaluation; Female; Humans; Life Tables; Male; Mesalamine; Middle Aged; Random Allocation; Recurrence; Remission Induction; Sulfasalazine | 1990 |
Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Therapy, Combination; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Prednisone; Recurrence; Remission Induction; Sulfasalazine | 1990 |
5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal?
Topics: Aminosalicylic Acids; Crohn Disease; Humans; Mesalamine; Recurrence | 1991 |
[Acute pancreatitis due to 5-aminosalicylic acid].
Topics: Acute Disease; Adult; Aminosalicylic Acids; Crohn Disease; Drug Therapy, Combination; Female; Humans; Mesalamine; Pancreatitis; Recurrence | 1991 |